Therapeutic Asset Ratings
6,308 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tipiracil
Exocrine Pancreatic Carcinoma
Emory University
P1/2
CCC
(48)
Tiragolumab
Atypical Teratoid Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tiragolumab
Epithelioid Sarcoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tiragolumab
Kidney Medullary Carcinoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tiragolumab
Follicular Lymphoma
Hoffmann-La Roche
P1/2
CCC
(48)
Tiragolumab
Poorly Differentiated Chordoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tiragolumab
Chordoma
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tiragolumab
Rhabdoid Tumor
National Cancer Institute (NCI)
P1/2
CCC
(48)
Tirapazamine
Digestive System Cancer
Teclison Ltd.
P1/2
CCC
(48)
Tislelizumab
Breast Neoplasm
BriaCell Therapeutics Corporation
P1/2
CCC
(48)
Tislelizumab
Lung Neoplasm
Novartis Pharmaceuticals
P1/2
CCC
(48)
Tislelizumab
Neuroendocrine Neoplasm
Harbour BioMed (Guangzhou) Co. Ltd.
P1/2
CCC
(48)
Tislezumab
Extranodal Nasal NK/T Cell Lymphoma
Fudan University
P1/2
CCC
(48)
Tislezumab
Lymphoma
Fudan University
P1/2
CCC
(48)
tng456
Glioblastoma
Tango Therapeutics, Inc.
P1/2
CCC
(48)
tng456
Lung Adenocarcinoma
Tango Therapeutics, Inc.
P1/2
CCC
(48)
Tobemstomig
Hepatocellular Carcinoma
Hoffmann-La Roche
P1/2
CCC
(48)
Tocilizumab
Ovarian Serous Adenocarcinoma
Regeneron Pharmaceuticals
P1/2
CCC
(48)
Tocilizumab
Endometrial Cancer
Regeneron Pharmaceuticals
P1/2
CCC
(48)
Tocilizumab
Fallopian Tube Cancer
Regeneron Pharmaceuticals
P1/2
CCC
(48)
Tocilizumab
Ovarian Cancer
Regeneron Pharmaceuticals
P1/2
CCC
(48)
Tocilizumab
Primary Peritoneal Carcinoma
Regeneron Pharmaceuticals
P1/2
CCC
(48)
Tocilizumab
Head And Neck Squamous Cell Carcinoma
Takeda
P1/2
CCC
(48)
Toripalimab
Thyroid Gland Papillary Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CCC
(48)
tqb2618
Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P1/2
CCC
(48)
Showing 1926 to 1950 of 6,308 assets
Previous
Page 78 of 253
Next